SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-037276
Filing Date
2020-11-16
Accepted
2020-11-16 14:21:18
Documents
43
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_cmlifesciences.htm 10-Q 272266
2 CERTIFICATION f10q0920ex31-1_cmlifescien.htm EX-31.1 11923
3 CERTIFICATION f10q0920ex31-2_cmlifescien.htm EX-31.2 11946
4 CERTIFICATION f10q0920ex32-1_cmlifescien.htm EX-32.1 4608
5 CERTIFICATION f10q0920ex32-2_cmlifescien.htm EX-32.2 4771
  Complete submission text file 0001213900-20-037276.txt   1833334

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cmlf-20200930.xml EX-101.INS 160349
7 XBRL SCHEMA FILE cmlf-20200930.xsd EX-101.SCH 33804
8 XBRL CALCULATION FILE cmlf-20200930_cal.xml EX-101.CAL 16942
9 XBRL DEFINITION FILE cmlf-20200930_def.xml EX-101.DEF 136835
10 XBRL LABEL FILE cmlf-20200930_lab.xml EX-101.LAB 245189
11 XBRL PRESENTATION FILE cmlf-20200930_pre.xml EX-101.PRE 140465
Mailing Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020
Business Address C/O CORVEX MANAGEMENT LP 667 MADISON AVENUE NEW YORK NY 10020 212 474 6700
CM Life Sciences, Inc. (Filer) CIK: 0001818331 (see all company filings)

IRS No.: 851966622 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39482 | Film No.: 201315598
SIC: 6770 Blank Checks